Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis

Cancer Science

Volumn 101, Issue 11, 2010, Pages 2375-2383

  Zhang, Ning ^a   Kong, Xiaoli ^a   Yan, Shi ^b   Yuan, Cunzhong ^b   Yang, Qifeng ^a  

^a Department of Breast Surgery ^*  (China)

^b Key Laboratory of Cardiovascular Proteomics of Shandong Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; FUNGAL EXTRACT; LIPOCORTIN 5; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; RHODAMINE 123; TRAMETES ROBINIOPHILA MURR EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AQUEOUS SOLUTION; ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG SENSITIVITY; FLOW CYTOMETRY; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; TRAMETES; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BASIDIOMYCOTA; BCL-2-ASSOCIATED X PROTEIN; BIOLOGICAL FACTORS; BLOTTING, WESTERN; BREAST NEOPLASMS; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77958599007     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01680.x     Document Type: Article

References (38)

1. Coughlin SS, Ekwueme DU. Breast cancer as a global health concern. Cancer Epidemiol 2009; 33: 315-8.
2. Breast cancer in developing countries. Lancet 2009 Nov 7; 374(9701): 1567.
3. Daniel FR. Breast Cancer (Second Edition). Philadelphia: Churchill Living-stone, 2005; 3-14.
4. Thomson CA, Thompson PA. Dietary patterns, risk and prognosis of breast cancer. Future Oncol 2009; 5: 1257-69.
5. Allinen M, Beroukhim R, Cai L et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004; 6: 17-32.
6. Pu CY, Lan VM, Lan CF, Lang HC. The determinants of traditional Chinese medicine and acupuncture utilization for cancer patients with simultaneous conventional treatment. Eur J Cancer Care (Engl) 2008; 17: 340-9.
7. Cohen I, Tagliaferri M, Tripathy D. Traditional Chinese medicine in the treatment of breast cancer. Semin Oncol 2002; 29: 563-74.
8. Cragg GM, Newman DJ. Discovery and development of antineoplastic agents from natural sources. Cancer Invest 1999; 17: 153-63.
9. Lee KH. Anticancer drug design based on plant-derived natural products. J Biomed Sci 1999; 6: 236-50.
10. Da Rocha AB, Lopes RM, Schwartsmann G. Natural products in anticancer therapy. Curr Opin Pharmacol 2001; 1: 364-9.
11. Li L, Ye S, Wang Y, Tang Z. Progress on experimental research and clinical application of Trametes robiniophila. China Cancer 2006; 16: 110-3.
12. Guo Y, Cheng P, Chen Y et al. Studies on the Constituents of Polysaccharide from the Hyphae of Trametes Robiniophila(II) - Identification of Polysaccharide from the Hyphae of Trametes Robiniophila and Determination of Its Molar Ratio. J Chin Pharm U 1992; 23: 155-7.
13. Guo Y, Cheng P, Chen Y et al. Isolation and analysis of the polysaccharide of Huaier mycelium. Chin J Biochem Pharm 1993; 63: 56-9.
14. Campbell MJ, Hamilton B, Shoemaker M, Tagliaferri M, Cohen I, Tripathy D. Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro. Anticancer Res 2002; 22: 3843-52.
15. Powell CB, Fung P, Jackson J et al. Aqueous extract of herba Scutellaria barbatae, a chinese herb used for ovarian cancer, induces apoptosis of ovarian cancer cell lines. Gynecol Oncol 2003; 91: 332-40.
16. Nizamutdinova IT, Lee GW, Son KH et al. Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells. Int J Oncol 2008; 33: 485-91.
17. Kamath L, Meydani A, Foss F, Kuliopulos A. Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells. Cancer Res 2001; 61: 5933-40.
18. Kim JB, Yu JH, Ko E et al. The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest. Phytomedicine 2010; 17: 436-40.
19. Albini A, Iwamoto Y, Kleinman HK et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 3239-45.
20. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007; 2: 329-33.
21. Arakawa Y, Bhawal UK, Ikoma T et al. Low concentration fluoride stimulates cell motility of epithelial cells in vitro. Biomed Res 2009; 30: 271-7.
22. Cheng YL, Chang WL, Lee SC et al. Acetone extract of Angelica sinensis inhibits proliferation of human cancer cells via inducing cell cycle arrest and apoptosis. Life Sci 2004; 75: 1579-94.
23. Zhou L, Chan WK, Xu N et al. Tanshinone IIA, an isolated compound from Salvia miltiorrhiza Bunge, induces apoptosis in HeLa cells through mitotic arrest. Life Sci 2008; 83: 394-403.
24. Nawrocki Raby B, Polette M, Gilles C et al. Quantitative cell dispersion analysis: new test to measure tumor cell aggressiveness. Int J Cancer 2001; 93: 644-52.
25. Van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998; 31: 1-9.
26. Ly JD, Grubb DR, Lawen A. The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis 2003; 8: 115-28.
27. Thatte U, Bagadey S, Dahanukar S. Modulation of programmed cell death by medicinal plants. Cell Mol Biol (Noisy-le-grand) 2000; 46: 199-214.
28. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-31.
29. Hui L, Zheng Y, Yan Y, Bargonetti J, Foster DA. Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D. Oncogene 2006; 25: 7305-10.
30. Lacroix M, Leclercq G. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 2004; 83: 249-89.
31. Sotiriou C, Pusztai L. Gene-expression signatures in breast cancer. N Engl J Med 2009; 360: 790-800.
32. Swami S, Raghavachari N, Muller UR, Bao YP, Feldman D. Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Res Treat 2003; 80: 49-62.
33. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770-6.
34. Pratt MA, White D, Kushwaha N, Tibbo E, Niu MY. Cytoplasmic mutant p53 increases Bcl-2 expression in estrogen receptor-positive breast cancer cells. Apoptosis 2007; 12: 657-69.
35. Yang Q, Sakurai T, Jing X et al. Expression of Bcl-2, but not Bax, correlates with estrogen receptor status and tumor proliferation in invasive breast carcinoma. Pathol Int 1999; 49: 775-80.
36. Eliopoulos AG, Kerr DJ, Herod J et al. The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. Oncogene 1995; 11: 1217-28.
37. Cho HJ, Kim JK, Kim KD et al. Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells. Cancer Lett 2006; 237: 56-66.
38. Yang Q, Sakurai T, Yoshimura G et al. Prognostic value of Bcl-2 in invasive breast cancer receiving chemotherapy and endocrine therapy. Oncol Rep 2003; 10: 121-5.